Lexeo Therapeutics Inc (LXEO)

Apr 04, 2025

Lexeo stock hits 52-week low at $2.31 amid sharp annual decline - Investing.com India

Apr 04, 2025

Apr 02, 2025

Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Given Average Rating of “Buy” by Brokerages - Defense World

Apr 02, 2025

Mar 29, 2025

Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Stock Holdings Raised by Bank of New York Mellon Corp - Defense World

Mar 29, 2025

Mar 29, 2025

What is Chardan Capital’s Estimate for LXEO FY2025 Earnings? - Defense World

Mar 29, 2025

Mar 29, 2025

Q1 EPS Estimate for Lexeo Therapeutics Increased by Analyst - Defense World

Mar 29, 2025

Mar 28, 2025

Lexeo Therapeutics (NASDAQ:LXEO) Price Target Lowered to $18.00 at Leerink Partners - MarketBeat

Mar 28, 2025

Mar 28, 2025

HC Wainwright Reaffirms Buy Rating for Lexeo Therapeutics (NASDAQ:LXEO) - Defense World

Mar 28, 2025

Mar 28, 2025

What is Leerink Partnrs’ Forecast for LXEO FY2025 Earnings? - Defense World

Mar 28, 2025

Mar 27, 2025

Lexeo Therapeutics Sees Biggest Retail Follower Surge Among Biotech Stocks After Record-Breaking Rally: What's The Big Draw? - MSN

Mar 27, 2025

Mar 27, 2025

Analysts Offer Predictions for LXEO Q1 Earnings - Defense World

Mar 27, 2025

Mar 26, 2025

Lexeo Therapeutics (NASDAQ:LXEO) Price Target Lowered to $20.00 at Royal Bank of Canada - Defense World

Mar 26, 2025

Mar 26, 2025

2 Stocks Riding the Biotech Surge With Major Catalysts Ahead - Investing.com

Mar 26, 2025

Mar 26, 2025

H.C. Wainwright maintains Buy on Lexeo stock, $23 target By Investing.com - Investing.com Canada

Mar 26, 2025

Mar 26, 2025

Lexeo Therapeutics (NASDAQ:LXEO) Receives “Buy” Rating from Chardan Capital - Defense World

Mar 26, 2025

Mar 26, 2025

Lexeo Therapeutics Sees Biggest Retail Follower Surge Among Biotech Stocks After Record-Breaking Rally: What's - Asianet Newsable

Mar 26, 2025

Mar 25, 2025

Pharma Frenzy: Volatility Ignites Biotech Sector - Sharewise

Mar 25, 2025

Mar 25, 2025

Why Lexeo Therapeutics (LXEO) Skyrocketed on Monday? - MSN

Mar 25, 2025

Mar 25, 2025

RBC Cuts Price Target on Lexeo Therapeutics to $20 From $24, Keeps Outperform, Speculative Risk - MarketScreener

Mar 25, 2025

Mar 25, 2025

Lexeo Therapeutics (NASDAQ:LXEO) Price Target Cut to $18.00 by Analysts at Leerink Partners - Defense World

Mar 25, 2025

Mar 25, 2025

Lexeo Therapeutics Advances Genetic Medicine Initiatives - TipRanks

Mar 25, 2025

Mar 24, 2025

10 Small Firms Kick Off Monday with Strong Gains - Insider Monkey

Mar 24, 2025

Mar 24, 2025

Leerink cuts Lexeo Therapeutics price target to $18, maintains Outperform By Investing.com - Investing.com Canada

Mar 24, 2025

Mar 24, 2025

Lexeo Therapeutics stock soars 40% on positive trial data By Investing.com - Investing.com South Africa

Mar 24, 2025

Mar 24, 2025

Lexeo Therapeutics stock soars 40% on positive trial data - Investing.com India

Mar 24, 2025

Mar 24, 2025

Lexeo Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 - MarketScreener

Mar 24, 2025

Mar 24, 2025

SEC Form 424B5 filed by Lexeo Therapeutics Inc. - Quantisnow

Mar 24, 2025

Mar 24, 2025

Lexeo Therapeutics May Offer And Sell Shares Of Common Stock Of Up To $75 MillionSEC Filing - Marketscreener.com

Mar 24, 2025

Mar 24, 2025

Lexeo Therapeutics, Inc. (LXEO) reports earnings - Quartz

Mar 24, 2025

Mar 24, 2025

Lexeo Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights - The Manila Times

Mar 24, 2025

Mar 16, 2025

Insider Stock Buyers At Lexeo Therapeutics Recouped Some Losses This Week - simplywall.st

Mar 16, 2025

Mar 16, 2025

Lexeo Therapeutics (NASDAQ:LXEO) & Monte Rosa Therapeutics (NASDAQ:GLUE) Critical Survey - Defense World

Mar 16, 2025

Mar 14, 2025

LEXEO THERAPEUTICS Earnings Preview: Recent $LXEO Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 14, 2025

Mar 11, 2025

Rhumbline Advisers Purchases 4,127 Shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - Defense World

Mar 11, 2025

Mar 08, 2025

Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Given Average Recommendation of “Buy” by Analysts - Defense World

Mar 08, 2025

Mar 03, 2025

Lexeo Therapeutics (LXEO) to Release Quarterly Earnings on Monday - Defense World

Mar 03, 2025

Feb 27, 2025

Lexeo stock hits 52-week low at $4.23 amid market challenges - MSN

Feb 27, 2025

Feb 25, 2025

Lexeo stock plunges to 52-week low at $3.42 amid market challenges By Investing.com - Investing.com South Africa

Feb 25, 2025

Feb 25, 2025

Lexeo stock plunges to 52-week low at $3.42 amid market challenges - Investing.com India

Feb 25, 2025

Feb 22, 2025

Lexeo Therapeutics chief medical officer sells $10,410 in stock By Investing.com - Investing.com South Africa

Feb 22, 2025

Feb 22, 2025

Lexeo Therapeutics CEO sells $19,090 in stock By Investing.com - Investing.com Nigeria

Feb 22, 2025

Feb 21, 2025

Top Executives at Lexeo Therapeutics Cash In on Stock Sales! - TipRanks

Feb 21, 2025

Feb 21, 2025

Lexeo Therapeutics chief development officer sells shares worth $6,557 - Investing.com

Feb 21, 2025

Feb 21, 2025

Lexeo Therapeutics CEO sells $19,090 in stock - Investing.com India

Feb 21, 2025

Feb 21, 2025

Lexeo Therapeutics chief medical officer sells $10,410 in stock - Investing.com India

Feb 21, 2025

Feb 21, 2025

Lexeo Therapeutics Executives Sell Shares for Tax Obligations - TradingView

Feb 21, 2025

Feb 21, 2025

Lexeo Therapeutics CMO Sells Shares to Cover Tax Obligations - TradingView

Feb 21, 2025